About SiSaf Ltd
SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon.The company’s Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improvethe stability, safety, and transfection efficiency of RNA. SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research partnerships.Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, it has fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.
Founded in 2008 by Suzanne Saffie-Siebert.
- Founded
- 2008
- Employees
- 11 to 50
- Total funding
- $28.6M
Leadership
The top of SiSaf Ltd's org chart, with how many people report into each leader.
Dr Suzanne Saffie-Siebert
Chairwoman & CEO
11 reports
Nissim Torabi-Pour
Chief Technical Officer
5 reports
John Stanton
Investor, Board Member, COO, Advisor
3 reports
Nichola Kinnear
Bookkeeper
Jobs at SiSaf Ltd
No open positions right now. Explore more companies on TheJobsMap.